Search
for
Sort by
Research 841–870 of 1000+
- Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the ‘future’ in dermatology therapeutics?
- Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome
- The emerging roles of N6-methyladenosine (m6A) deregulation in polycystic ovary syndrome
- Small Molecule Agents Against Alopecia: Potential Targets and Related Pathways
- Successful topical minoxidil treatment for hair density and length in trichorhinophalangeal syndrome type 1
- Current aspects of polycystic ovary syndrome II: treatment of hyperandrogenism, insulin resistance and infertility
- Impact of Medical Castration on Malignant Arrhythmias in Patients With Prostate Cancer
- Comment on: The Gabrin sign
- The Association between COVID-19 Infection and Gabrin Sign: A Case-Control Study
- An Approach to the Patient With Hirsutism
- Female pattern hair loss: Art and science of successful treatment of hair loss in women
- The control of hair growth.
- Comprehensive clinical management of polycystic ovary syndrome.
- Efficacy, safety and tolerability of drugs for alopecia: a comprehensive review
- Noninvasive Hair Rejuvenation
- Hormonale Diagnostik der sogenannten androgenetischen Alopezie der Frau
- Hormonal Therapies in Cosmetic Dermatology: Mechanisms, Clinical Applications, and Future Perspectives
- Androgens/Androgen Receptor in the Management of Skin Diseases
- Steroidogenesis inhibitors alter but do not eliminate androgen synthesis mechanisms during progression to castration-resistance in LNCaP prostate xenografts
- Hormonal Treatment Strategies Tailored to Non-Binary Transgender Individuals
- Role of insulin resistance and diet in acne
- To evaluate the causes and possible treatments for alopecia seborrheic in adolescents
- Optimal use of topical minoxidil in management of female pattern hair loss in India: an expert opinion
- Polycystic ovary syndrome: Diagnosis and management
- Inositol versus Metformin administration in polycystic ovary syndrome patients
- Alopecia in patients with COVID-19: A systematic review and meta-analysis
- Cosmeceutical and Dermatological Potential of Olive Mill Wastewater: A Sustainable and Eco-Friendly Source of Natural Ingredients
- Safety of Alopecia Treatments in Patients with Breast Cancer and High-Risk Women: A Review
- Cosmetic and Dermatological Properties of Olive Oil Byproduct-Supplemented Skin and Hair Care Products
- Secondary Amenorrhea and Clinical Hyperandrogenism in a 34-Year-Old Female: Polycystic Ovary Syndrome or Not?